Home > Healthcare > Medical Devices > Therapeutic Devices > Heart Pump Device Market

Heart Pump Device Market Share

Report ID: GMI8787
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Heart Pump Device Market Share

The heart pump device industry is consolidated, with a few major multinational companies dominating the market. This consolidation reduces competition, as large corporations control the majority of market share. In such a landscape, the focus on innovation remains crucial for maintaining market leadership. These key players continuously invest in research and development to introduce advanced technologies and therapies that meet evolving clinical needs while optimizing cost-effectiveness. This emphasis on innovation allows dominant companies to solidify their market position and drive growth in the heart pump device industry.

Heart Pump Device Market Companies

Some of the eminent market participants operating in the heart pump device industry include:

Abbott Laboratories
ABIOMED
Berlin Heart
BiVACOR Inc.
CARMAT
CorWave SA
Evaheart, Inc.
Fresenius SE & Co. KGaA
Getinge AB
Jarvik Heart
Leviticus Cardio
LivaNova PLC
Medtronic plc
SynCardia Systems, LLC
Teleflex Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of heart pump device crossed USD 2.2 billion in 2023 and is set to reach USD 9.2 billion by 2032, led by increase in number of heart failures and cardiovascular diseases.

Implanted heart pump devices segment is anticipated to reach USD 6.4 billion by 2032, owing to its durability and reliability in providing mechanical circulatory support for patients with chronic heart failure.

North America heart pump device industry accounted for USD 917.6 million in revenue in 2023, driven by technological innovation and medical device development.

Abbott Laboratories, ABIOMED, Berlin Heart, BiVACOR Inc., CARMAT, CorWave SA, Evaheart, Inc., Fresenius SE & Co. KGaA, and Getinge AB among others.